Dec
23
Constellation Pharmaceuticals Awarded Incentive from Massachusetts Life Sciences Center
Posted in Constellation in the News, NewsroomCambridge, MA – December 23, 2009 – Constellation Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing new drugs targeting epigenetic regulation of the human genome, today announced that it is selected as one of twenty-eight life sciences companies to participate in $25 million in Tax Incentives awarded by the Massachusetts Life Sciences [...]